Decheng Capital Management Iii (Cayman), LLC I Mab Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in I Mab stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 4,166,667 shares of IMAB stock, worth $8.71 Million. This represents 3.04% of its overall portfolio holdings.
Number of Shares
4,166,667Holding current value
$8.71 Million% of portfolio
3.04%Shares
1 transactions
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.8MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$12.5 Million0.15% of portfolio
-
Sg Americas Securities, LLC822KShares$1.72 Million0.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR484KShares$1.01 Million0.39% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$759,0880.0% of portfolio
-
Ubs Group Ag319KShares$665,7610.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $174M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...